ARENA PHARMACEUTICALS INC (ARNA) Stock Cash Flow
NASDAQ:ARNA - Nasdaq - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -616.43M | -404.70M | 397.60M | -29.40M | -92.70M | |||
| Depreciation Amortization | 3.87M | 3.90M | 3.20M | 3.80M | 4.30M | |||
| Income Taxes - Deferred | 0.00 | N/A | 110.30M | -110.30M | N/A | |||
| Change In Working Capital | 29.79M | -800.00K | 6.20M | -10.10M | 8.20M | |||
| Interest Paid | 4.08M | 4.50M | 4.80M | 5.70M | 6.00M | |||
| Other non cash items | 130.75M | 48.60M | 51.40M | 13.90M | 13.60M | |||
| OPERATING CASH FLOW | -452.02M | -353.10M | 568.70M | -132.20M | -66.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -70.99M | -800.00K | -4.80M | -700.00K | -100.00K | |||
| Other Investing Activity | 392.39M | -20.60M | -492.10M | -250.60M | -112.30M | |||
| INVESTING CASH FLOW | 321.40M | -21.40M | -496.90M | -251.30M | -112.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -4.40M | -3.80M | -3.30M | -4.00M | -3.50M | |||
| Stock Issued/Repurchased | 139.81M | 354.40M | 13.10M | 389.00M | 248.80M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | N/A | |||
| FINANCING CASH FLOW | 135.41M | 350.60M | 9.90M | 385.00M | 245.30M | |||
| Exchange Rate Effect | 236.00K | 200.00K | 0.00 | 700.00K | 1.90M | |||
| CHANGE IN CASH | 5.03M | -23.70M | 81.70M | 2.20M | 68.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -452.02M | -353.10M | 568.70M | -132.20M | -66.60M | |||
| Capital Expenditure | -70.99M | -800.00K | -4.80M | -700.00K | -100.00K | |||
| FREE CASH FLOW | -523.00M | -353.90M | 563.90M | -132.90M | -66.70M | |||
All data in USD